Transdermal and skin-targeted drug delivery

Journal of Cutaneous Medicine and Surgery

Volumn 2, Issue 2, 1997, Pages 108-119

  Merino, Virginia ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DICLOFENAC; DRUG VEHICLE; ESTRADIOL; ESTRIOL; FENTANYL; GLYCERYL TRINITRATE; GONADORELIN; LIPOSOME; NAFARELIN; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; RETINOIC ACID; SCOPOLAMINE; TESTOSTERONE;

DIABETES MELLITUS; DROWSINESS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; GLUCOSE BLOOD LEVEL; HUMAN; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SKIN; SKIN DISEASE; SUBCUTANEOUS TISSUE; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031391664     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549700200212     Document Type: Review

References (33)

1. Guy RH, Kalia YN, Lim CS, et al. Drug smuggling - creative ways to cross biological barriers. Chemistry in Britain 1996; 32: 42-45.
2. Guy RH. Current status and future prospects of transdermal drug delivery. Pharm Res 1996; 13:1765-1769.
3. Elias PM. Epidermal barrier: intracellular lamellar lipid structures, origin, composition and metabolism. J Control Release 1991; 15: 199-208.
4. Forslind B. A domain mosaic model of the skin barrier. Acta Derm Venereol (Stockh) 1994; 74:1-6.
5. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971; 51:702-747.
6. Elias PM, Friend DS. The permeability barrier in mammalian epidermis. J Cell Biol 1975; 65:180-191.
7. Blank IH. Cutaneous barriers. J Invest Dermatol 1965; 45: 249-256.
8. Potts RO, Francoeur ML. Lipid biophysics of water loss through the skin. Proc Nad Acad Sci USA 1990; 87:3871-3873.
9. Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol 1991; 96: 495-499.
10. Guy RH, Hadgraft J. Transdermal drug delivery: the ground rules are emerging. Pharm Int 1985; 6:112-116.
11. Kalia YN, Pirot F, Guy RH. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J 1996; 71: 2692-2700.
12. Shah VP, Behl CR, Flynn GL, et al. Principles and criteria in the development and optimization of topical therapeutic products. Skin Pharmacol 1993; 6:72-80.
13. Addicks WJ, Weiner ND, Curl RL, Flynn GL. Drug delivery from topical formulations: theoretical prediction and experimental assessment. In: Osborne DW, Amann AH, eds. Topical drug delivery formulations. New York: Marcel Dekker, 1990:221-244.
14. Davis AF, Hadgraft J. The use of supersaturation in topical drug delivery. In: Scott RC, Guy RH, Hadgraft J, eds. Prediction of percutaneous penetration, Vol. 2. London: IBC Technical Services, 1991:279-287.
15. Hadgraft J, Wolff M. Physicochemical and pharmacokinetic parameters affecting percutaneous absorption. In: Gurny R, Teubner A, eds. Dermal and transdermal drug delivery. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1993:161-172.
16. Barry BW. Properties that influence percutaneous absorption. In: Barry BW, ed. Dermatological formulations: percutaneous absorption. New York: Marcel Dekker, 1983:127-233.
17. Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. Boca Raton: CRC Press, 1995.
18. Ghosh TK, Banga AK. Methods of enhancement of transdermal drug delivery. Part 2A. Chemical permeation enhancers. Pharm Technol 1993; 17:62-90.
19. Weiner N, Martin F, Riaz M. Liposomes as a drug delivery system. Drug Dev Ind Pharm 1989; 15:1523-1554.
20. Uster PS. Liposome-based vehicles for topical delivery. In: Osborne DW, Amann AH, eds. Topical drug delivery formulations. New York: Marcel Dekker, 1990:327-348.
21. Lauer AC, Ramachandran C, Lieb LM, et al. Targeted delivery, to the pilosebaceous unit via liposomes. Adv Drug Deliv Rev 1996; 18:311-324.
22. Cevc C, Blume G, Schätzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev 1996; 18:349-378.
23. Cooper ER, Patel DC. Practical considerations for topical drug formulations with and without enhancers. In: Osborne DW, Amann AH, eds. Topical drug delivery formulations. New York: Marcel Dekker, 1990:1-12.
24. Ongpipattanakul B, Burnette RR, Potts RO, et al. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res 1991; 8:350-354.
25. Franz TJ, Lehman PA, Kagy MK. Dimethylsulfoxide. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. Boca Raton: CRC Press, 1995:115-127.
26. Chien YW. Transdermal drug delivery and delivery systems. In: Chien YW, ed. Novel drug delivery systems. 2nd Ed. New York: Marcel Dekker, 1992:301-380.
27. Zatz JL. Assessment of vehicle factors influencing percutaneous absorption. In: Bronaugh RL, Maibach HI, eds. In vitro percutaneous absorption: principles, fundamentals and applications. Boca Raton: CRC Press, 1991:51-66.
28. Ziegenmeyer J. The influence of the vehicle on the absorption and permeation of drugs. In: Brandau R, Lippold BH, eds. Dermal and transdermal absorption. Stuttgart: Wissenschaftliche Verlagsgeselischaft, 1982:73-89.
29. Martin C, Dupont C, Samour C, et al. Non-invasive evaluation of the effect of 2n-nonyl-1,3-dioxolane on the cutaneous barrier properties of healthy volunteers. Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials 1994; 21:407-408.
30. Wester RC, Maibach HI. Penetration enhancement by skin hydration. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. Boca Raton: CRC Press, 1995:21-28.
31. Haigh JM, Smith EW. Hydration and topical corticosteroid absorption. In: Smith EW, Maibach HI, eds. Percutaneous penetration enhancers. Boca Raton: CRC Press, 1995:29-34.
32. Mak VHW, Potts RO, Guy RH. Does hydration affect intercellular lipid organisation in the stratum corneum. Pharm Res 1991; 8:1064-1065.
33. Bouwstra JA, Gooris GS, Salomondevries MA, et al. Structure of human stratum corneum as a function of temperature and hydration - a wide-angle x-ray diffraction study. Int J Pharm 1992; 84:205-216.